HMDBP00058 | Calcium-dependent phospholipase A2 | P39877 | PLA2G5 | 1p36-p34 | Unknown | Not Available |
HMDBP00059 | Group IIF secretory phospholipase A2 | Q9BZM2 | PLA2G2F | 1p35 | Unknown | Not Available |
HMDBP00060 | Cytosolic phospholipase A2 | P47712 | PLA2G4A | 1q25 | Unknown | Not Available |
HMDBP00061 | Phospholipase A2 | P04054 | PLA2G1B | 12q23-q24.1 | Unknown | Not Available |
HMDBP00062 | Group XIIB secretory phospholipase A2-like protein | Q9BX93 | PLA2G12B | | Unknown | Not Available |
HMDBP00063 | Group 10 secretory phospholipase A2 | O15496 | PLA2G10 | 16p13.1-p12 | Unknown | Not Available |
HMDBP00065 | Group IIE secretory phospholipase A2 | Q9NZK7 | PLA2G2E | 1p36.13 | Unknown | Not Available |
HMDBP00067 | Group XIIA secretory phospholipase A2 | Q9BZM1 | PLA2G12A | 4q25 | Unknown | Not Available |
HMDBP00068 | 85/88 kDa calcium-independent phospholipase A2 | O60733 | PLA2G6 | 22q13.1 | Unknown | Not Available |
HMDBP00072 | Phospholipase A2, membrane associated | P14555 | PLA2G2A | 1p35 | Unknown | Not Available |
HMDBP00073 | Group IID secretory phospholipase A2 | Q9UNK4 | PLA2G2D | 1p36.12 | Unknown | Not Available |
HMDBP00529 | Cytosolic phospholipase A2 gamma | Q9UP65 | PLA2G4C | 19q13.3 | Unknown | Not Available |
HMDBP00532 | Group 3 secretory phospholipase A2 | Q9NZ20 | PLA2G3 | 22q12.2 | Unknown | Not Available |
HMDBP00549 | Bile acid-CoA:amino acid N-acyltransferase | Q14032 | BAAT | 9q22.3 | Enzyme | Not Available |
HMDBP01046 | Cytosolic acyl coenzyme A thioester hydrolase | O00154 | ACOT7 | 1p36 | Enzyme | Not Available |
HMDBP01047 | Acyl-coenzyme A thioesterase 2, mitochondrial | P49753 | ACOT2 | 14q24.3 | Enzyme | Not Available |
HMDBP01048 | Acyl-coenzyme A thioesterase 4 | Q8N9L9 | ACOT4 | 14q24.3 | Enzyme | Not Available |
HMDBP01049 | Acyl-coenzyme A thioesterase 8 | O14734 | ACOT8 | 20q13.12 | Enzyme | Not Available |
HMDBP02234 | Transient receptor potential cation channel subfamily V member 1 | Q8NER1 | TRPV1 | 17p13.2 | Unknown | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
|
HMDBP02649 | Fatty acid desaturase 1 | O60427 | FADS1 | 11q12.2-q13.1 | Unknown | - Xiang M, Rahman MA, Ai H, Li X, Harbige LS: Diet and gene expression: delta-5 and delta-6 desaturases in healthy Chinese and European subjects. Ann Nutr Metab. 2006;50(6):492-8. Epub 2006 Sep 19. [PubMed:16988497 ]
- Descomps B, Rodriguez A: [Essential fatty acids and prematurity: a triple experimental approach]. C R Seances Soc Biol Fil. 1995;189(5):781-96. [PubMed:8673626 ]
- Hoffman DR, DeMar JC, Heird WC, Birch DG, Anderson RE: Impaired synthesis of DHA in patients with X-linked retinitis pigmentosa. J Lipid Res. 2001 Sep;42(9):1395-401. [PubMed:11518758 ]
- Maniongui C, Blond JP, Ulmann L, Durand G, Poisson JP, Bezard J: Age-related changes in delta 6 and delta 5 desaturase activities in rat liver microsomes. Lipids. 1993 Apr;28(4):291-7. [PubMed:8487621 ]
- Mohan IK, Das UN: Effect of L-arginine-nitric oxide system on the metabolism of essential fatty acids in chemical-induced diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids. 2000 Jan;62(1):35-46. [PubMed:10765977 ]
|
HMDBP03051 | Sodium/calcium exchanger 1 | P32418 | SLC8A1 | 2p23-p22 | Unknown | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
- Ander BP, Hurtado C, Raposo CS, Maddaford TG, Deniset JF, Hryshko LV, Pierce GN, Lukas A: Differential sensitivities of the NCX1.1 and NCX1.3 isoforms of the Na+-Ca2+ exchanger to alpha-linolenic acid. Cardiovasc Res. 2007 Jan 15;73(2):395-403. Epub 2006 Sep 23. [PubMed:17059813 ]
|
HMDBP03232 | Fatty acid desaturase 2 | O95864 | FADS2 | 11q12.2 | Unknown | - Ge L, Gordon JS, Hsuan C, Stenn K, Prouty SM: Identification of the delta-6 desaturase of human sebaceous glands: expression and enzyme activity. J Invest Dermatol. 2003 May;120(5):707-14. [PubMed:12713571 ]
- Xiang M, Rahman MA, Ai H, Li X, Harbige LS: Diet and gene expression: delta-5 and delta-6 desaturases in healthy Chinese and European subjects. Ann Nutr Metab. 2006;50(6):492-8. Epub 2006 Sep 19. [PubMed:16988497 ]
- Portolesi R, Powell BC, Gibson RA: Competition between 24:5n-3 and ALA for Delta 6 desaturase may limit the accumulation of DHA in HepG2 cell membranes. J Lipid Res. 2007 Jul;48(7):1592-8. Epub 2007 Apr 4. [PubMed:17409318 ]
- Baylin A, Ruiz-Narvaez E, Kraft P, Campos H: alpha-Linolenic acid, Delta6-desaturase gene polymorphism, and the risk of nonfatal myocardial infarction. Am J Clin Nutr. 2007 Feb;85(2):554-60. [PubMed:17284757 ]
- Li MC, Bu YP, Wang GK, Hu GW, Xing LJ: [Heteologous expression of Mortierella isabellina delta6 -fatty acid desaturase gene in soybean]. Yi Chuan Xue Bao. 2004 Aug;31(8):858-63. [PubMed:15481543 ]
- Tan L, Meesapyodsuk D, Qiu X: Molecular analysis of 6 desaturase and 6 elongase from Conidiobolus obscurus in the biosynthesis of eicosatetraenoic acid, a omega3 fatty acid with nutraceutical potentials. Appl Microbiol Biotechnol. 2011 Apr;90(2):591-601. doi: 10.1007/s00253-010-3060-y. Epub 2011 Jan 6. [PubMed:21210105 ]
|
HMDBP04479 | Elongation of very long chain fatty acids protein 4 | Q9GZR5 | ELOVL4 | 6q14 | Enzyme | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
|
HMDBP07301 | Phospholipase B1, membrane-associated | Q6P1J6 | PLB1 | 2p23.2 | Unknown | Not Available |
HMDBP07863 | Cytosolic phospholipase A2 delta | Q86XP0 | PLA2G4D | 15q15.1 | Unknown | Not Available |